Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3013228203.
Violations1
Issue DateJan 8, 2025
Product TypeTobacco
StatusOpen
Letter Details
Firm
Reedhill Ventures LLC, d/b/a Vape On
Location
Reedhill Ventures LLC, d/b/a Vape On
13320 Emmett Road
Houston , TX 77041
United States
FEI Number
3013228203
Country
United States
Issue Date
January 08, 2025
Issuing Office
Center for Tobacco Products
Product Type
Tobacco
Status
Open
Summary
Reedhill Ventures LLC, operating as Vape On, was cited for manufacturing and distributing e-liquid tobacco products without required premarket authorization from the FDA. The company's nicotine-containing e-liquid products were determined to be subject to FDA jurisdiction under the Federal Food, Drug, and Cosmetic Act, including products containing nicotine from any source following the 2022 legislative expansion of tobacco product definitions. As "new tobacco products" not commercially marketed before February 15, 2007, the e-liquids required premarket approval orders before being legally marketed in the United States, which the company had failed to obtain.
Reedhill Ventures LLC, d/b/a Vape On FDA Warning Letter, January 8, 2025